Skip to main content
. 2014 Oct 14;4:6609. doi: 10.1038/srep06609

Figure 1.

Figure 1

Top: Under “bypass hypothesis”, in situ binding kinetics of Herceptin with resistant cell was not affected. Bottom: “Alternation hypothesis” suggests an altered binding kinetics due to the influences of relevant proteins surrounding Her2.